NAT10 and hepatocellular carcinoma: NAT10-mediated ac4C modification of HMGB2 mRNA, and the ac4C sites in the CDS of HMGB2 mRNA enhance eEF2 binding, promoting translation elongation of HMGB2 mRNA, thereby critically driving HCC progression and metastatic dissemination [102].